Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 14/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 9/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.38 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.37 |
| ▸ | CHKA | P35790 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24601147 | 0.88 | ADORA3 (0.49) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL29073648 | 0.88 | ADORA3 (0.51) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL29762104 | 0.88 | ADORA3 (0.51) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL29073660 | 0.88 | ADORA3 (0.51) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL26628433 | 0.88 | ADORA3 (0.51) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL24601549 | 0.84 | ADORA3 (0.49) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL24601198 | 0.80 | TSHR (0.49) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL24600675 | 0.80 | ADORA3 (0.46) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL26753672 | 0.79 | ADORA3 (0.51) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL29762189 | 0.79 | ADORA3 (0.52) | ADORA3ADORA1ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022143740-A1 | ADENOSINE A3 RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF | 浙江春禾医药科技有限公司 | 2022-07-07 | — | — | WO | disclosed |